Next 10 |
home / stock / vxrt / vxrt articles
Palo Alto Networks, Inc. (NASDAQ:PANW) reported its third-quarter financial results after the bell Monday. Here's a look at the details from t...
Vaxart, Inc. (NASDAQ:VXRT) reported its first-quarter financial results after the bell Monday. Here's a look at the details. The Details...
SOUTH SAN FRANCISCO, Calif., March 20, 2024 (GLOBE NEWSWIRE) -- Vaxart, Inc. (NASDAQ:VXRT) (the "Company" or "Vaxart") today announced that the ...
Shares of Advanced Micro Devices, Inc. (NASDAQ: AMD) shares declined 3.8% to $165.49 following fourth-quarter results. AMD reported fourth-quarter ...
Vaxart Inc (NASDAQ:VXRT) shares are trading higher by 8.4% to $0.79 Wednesday afternoon amid ongoing volatility and a numb...
Vaxart Inc (NASDAQ:VXRT) shares are trading higher by 17.8% to $0.66 Tuesday morning amid a number of recent news items. The company recently secur...
SOUTH SAN FRANCISCO, Calif., Jan. 16, 2024 (GLOBE NEWSWIRE) -- Vaxart, Inc. (NASDAQ:VXRT) today announced that it has entered into a common stoc...
Chief Executive Officer Andrei Floroiu Resigns Chair Michael J. Finney, Ph.D. to Serve as Interim Chief Executive Officer SOUTH SAN FRANCISCO, Cal...
Gainers Miromatrix Medical Inc. (NASDAQ: MIRO) shares jumped 232% to $3.36 in pre-market trading. United Therapeutics Corporation (N...
News, Short Squeeze, Breakout and More Instantly...
Palo Alto Networks, Inc. (NASDAQ:PANW) reported its third-quarter financial results after the bell Monday. Here's a look at the details from t...
Vaxart, Inc. (NASDAQ:VXRT) reported its first-quarter financial results after the bell Monday. Here's a look at the details. The Details...
Positive results from Phase 1 norovirus study in lactating mothers indicate the potential of Vaxart’s oral pill vaccine candidate to protect or reduce the effect of the disease in infants Expects to initiate Phase 2b study evaluating Vaxart’s oral pill XBB COVID-19 vaccine a...